Yahoo Web Search

Search results

1. • Randomized, double-blind, multicenter, active-controlled, noninferiority trial

     • A randomized, double-blind, multicenter, active-controlled, noninferiority trial in 645 treatment-naïve (≥18 years) patients with HIV-1. Study 1490 was designed to assess whether BIC/FTC/TAF was noninferior to DTG+FTC/TAF
     Reference:

     Study 1490 Clinical Trial with TIVICAY - tivicayhcp.com

2. People also ask

   What is a 1490 SAT score?

   • The SAT is calculated out of 1600 points which is the highest score you can achieve. On the other hand, a 400 is the lowest possible score. A 1490 SAT score indicates that you have a great grasp of collegiate-level material and have no problem excelling in college curricula. With a 1490 SAT score, you’re in the top 2% of performers.

   Is 1490 a Good SAT Score? | AdmissionSight

   admissionsight.com/is-1490-a-good-sat-score/

   See all results for this question

   What is the difference between study 1489 and study 1490?

   • Study 1489 enrolled a slightly younger population (mean age 34 years) compared with Study 1490 (mean age 37 years). The majority of patients in both studies were male (90%). Patients enrolled in both studies were mostly white (> 55%). The proportion of black patients enrolled was slightly greater in Study 1489 (35%) compared with Study 1490 (30%).

   Results - Clinical Review Report: Bictegravir ... - NCBI Bookshelf

   www.ncbi.nlm.nih.gov/books/NBK539530/

   See all results for this question

   What is the primary outcome of study 1489 and study 1490?

   • The primary outcome in Study 1489 and Study 1490 was the proportion of patients with HIV-1 RNA < 50 copies/mL at week 48, as determined by the US FDA-defined snapshot algorithm in the full analysis set ( FAS) population.

   Results - Clinical Review Report: Bictegravir ... - NCBI Bookshelf

   www.ncbi.nlm.nih.gov/books/NBK539530/

   See all results for this question

   What are the baseline characteristics of study 1489 and study 1490?

   • Baseline characteristics in both Study 1489 and Study 1490 were well balanced between treatment groups. Study 1489 enrolled a slightly younger population (mean age 34 years) compared with Study 1490 (mean age 37 years). The majority of patients in both studies were male (90%). Patients enrolled in both studies were mostly white (> 55%).

   Results - Clinical Review Report: Bictegravir ... - NCBI Bookshelf

   www.ncbi.nlm.nih.gov/books/NBK539530/

   See all results for this question

3. www.ncbi.nlm.nih.gov › books › NBK539530Results

   www.ncbi.nlm.nih.gov › books › NBK539530

   Study 1489 (N = 631; nine countries) and Study 1490 (N = 657; 10 countries) are phase III, randomized (1:1), multi-centre, double-blind, parallel-group, noninferiority trials. Randomization was stratified by HIV-1 RNA level (≤ 100,000 copies/mL, > 100,000 to ≤ 400,000 copies/mL, or > 400,000 copies/mL), CD4 cell count (< 50 cells/µL, 50 to ...

   • Table 19

     The .gov means it's official. Federal government websites...

   • Treatment-Experienced/Switch

     The .gov means it's official. Federal government websites...

   • Full Analysis Set

     Other reasons include investigator’s discretion, subject...

   • Discussion

     < Prev Next > Discussion. Go to: Summary of Available...

4. www.gilead.com › news-and-press › press-roomPress Releases - Gilead Sciences

   www.gilead.com › news-and-press › press-room

   • Cached

   Jul 17, 2021 · Study 1489 and Study 1490 are Phase 3, double-blind, active-controlled studies. For 144 weeks, treatment-naïve participants were blinded to receive either Biktarvy (n=634) or a dolutegravir-containing triple therapy (n=640).

5. www.collegesimply.com › guides › 1490-on-the-sat1490 SAT Score : Popular Colleges You Can Get Into for 2024

   www.collegesimply.com › guides › 1490-on-the-sat

   • Cached

   A 1490 converts to a 34 on the ACT using College Board / ACT concordance tables. Explore the colleges: Colleges for a 34 ACT score. Discover the colleges that accept a 1490 on the SAT.

   • Yes, a score of 1490 is awesome. The score puts you in the top 99th percentile of those who take the test. Explore colleges you can get into with a...
   • Harvard University, Stanford University and University of Florida are some of the best colleges that you have a competitive chance of getting into....
   • A 1490 ranks in the top 99th percentile of all students who take the SAT exam.

6. admissionsight.com › is-1490-a-good-sat-scoreIs 1490 a Good SAT Score? | AdmissionSight

   admissionsight.com › is-1490-a-good-sat-score

   • Cached

   Mar 29, 2023 · A 1490 SAT score indicates that you have a great grasp of collegiate-level material and have no problem excelling in college curricula. With a 1490 SAT score, you’re in the top 2% of performers. In other words, you received a higher score than 98% of other test takers which will automatically help you stand out in the college admissions process.

7. www.businesswire.com › news › homeBiktarvy® Demonstrates High Efficacy and Durable Viral ...

   www.businesswire.com › news › home

   • Cached

   Mar 6, 2021 · Study 1489 and Study 1490 are Phase 3, randomized, double-blind, active-controlled studies. For 144 weeks, treatment-naïve participants were blinded to receive either Biktarvy (n=634) or a...

8. www.tivicayhcp.com › clinical-trials › STUDY-1490Study 1490 Clinical Trial with TIVICAY - tivicayhcp.com

   www.tivicayhcp.com › clinical-trials › STUDY-1490

   • Cached

   GILEAD-SPONSORED TRIAL—STUDY 1490: SEE HOW A DOLUTEGRAVIR-BASED REGIMEN COMPARED WITH A BICTEGRAVIR-BASED REGIMEN. A randomized, double-blind, multicenter, active-controlled, noninferiority trial in 645 treatment-naïve (≥18 years) patients with HIV-1.